Literature DB >> 20044742

Decreased NKCC1 activity in erythrocytes from African Americans with hypertension and dyslipidemia.

Sergei N Orlov1, Francis Gossard, Zdenka Pausova, Olga A Akimova, Johanne Tremblay, Clarence E Grim, Jane M Kotchen, Theodore A Kotchen, Daniel Gaudet, Allen W Cowley, Pavel Hamet.   

Abstract

BACKGROUND: Recent studies demonstrated a key role of ubiquitous isoform of Na+,K+,2Cl- co-transport (NKCC1) in regulation of myogenic tone and peripheral resistance. We examined the impact of race, gender, and plasma lipid on NKCC1 activity in French Canadians and African Americans with hypertension and dyslipidemia.
METHODS: NKCC and passive erythrocyte membrane permeability to K+, measured as ouabain-resistant, bumetanide-sensitive, and (ouabain+bumetanide)-resistant 86Rb influx, respectively, were compared in 111 French-Canadian men, 107 French-Canadian women, 26 African-American men, and 45 African-American women with essential hypertension and dyslipidemia.
RESULTS: The African-American men and women were 7 years younger and presented twofold decreased plasma triglycerides compared to their French-Canadian counterparts (P < 0.01) whereas body mass index (BMI), total cholesterol, low-density lipoprotein, and high-density lipoprotein (HDL) were not different. NKCC was respectively 50 and 38% lower in the African-American men and women than in the French Canadians (P < 0.005) without any differences in passive erythrocyte membrane permeability for K+. We did not observe any impact of age on NKCC in all groups under investigation, whereas plasma triglycerides correlated positively with the activity of this carrier in the French-Canadian men only.
CONCLUSIONS: NKCC1 activity is lower in erythrocytes of African Americans with essential hypertension and dyslipidemia than in Caucasian counterparts. We suggest that decreased NKCC1 may contribute to the feature of the pathogenesis of salt-sensitive hypertension seen in African Americans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20044742      PMCID: PMC3727424          DOI: 10.1038/ajh.2009.249

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  38 in total

Review 1.  Signaling mechanisms underlying the vascular myogenic response.

Authors:  M J Davis; M A Hill
Journal:  Physiol Rev       Date:  1999-04       Impact factor: 37.312

2.  Sibling resemblance of erythrocyte ion transporters in French-Canadian sibling-pairs affected with essential hypertension.

Authors:  S N Orlov; Z Pausova; F Gossard; D Gaudet; J Tremblay; T Kotchen; A Cowley; P Larochelle; P Hamet
Journal:  J Hypertens       Date:  1999-12       Impact factor: 4.844

Review 3.  Chloride in smooth muscle.

Authors:  A R Chipperfield; A A Harper
Journal:  Prog Biophys Mol Biol       Date:  2000       Impact factor: 3.667

4.  Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf.

Authors:  M Flagella; L L Clarke; M L Miller; L C Erway; R A Giannella; A Andringa; L R Gawenis; J Kramer; J J Duffy; T Doetschman; J N Lorenz; E N Yamoah; E L Cardell; G E Shull
Journal:  J Biol Chem       Date:  1999-09-17       Impact factor: 5.157

5.  Effects of inhibition of the Na+/K+/2Cl- cotransporter on myogenic and angiotensin II responses of the rat afferent arteriole.

Authors:  Xuemei Wang; Jennifer Breaks; Kathy Loutzenhiser; Rodger Loutzenhiser
Journal:  Am J Physiol Renal Physiol       Date:  2006-11-07

Review 6.  Genetic and biochemical determinants of abnormal monovalent ion transport in primary hypertension.

Authors:  S N Orlov; N C Adragna; V A Adarichev; P Hamet
Journal:  Am J Physiol       Date:  1999-03

Review 7.  Cardiovascular risk reduction among African Americans: a call to action.

Authors:  Karol E Watson
Journal:  J Natl Med Assoc       Date:  2008-01       Impact factor: 1.798

8.  Altered permeability of the erythrocyte membrane for sodium and potassium ions in spontaneously hypertensive rats.

Authors:  Y U Postnov; S Orlov; P Gulak; A Shevchenko
Journal:  Pflugers Arch       Date:  1976-09-30       Impact factor: 3.657

9.  What can we learn from erythrocyte Na-K-Cl cotransporter NKCC1 in human hypertension?

Authors:  Ricardo P Garay; Octavio Alda
Journal:  Pathophysiology       Date:  2007-10-17

10.  Aldosterone and alterations of hypertension-related vascular function in African Americans.

Authors:  Theodore A Kotchen; Jane M Kotchen; Clarence E Grim; Shanthi Krishnaswami; Srividya Kidambi
Journal:  Am J Hypertens       Date:  2008-12-18       Impact factor: 2.689

View more
  4 in total

1.  Volume regulation in mammalian skeletal muscle: the role of sodium-potassium-chloride cotransporters during exposure to hypertonic solutions.

Authors:  Michael I Lindinger; Matthew Leung; Karin E Trajcevski; Thomas J Hawke
Journal:  J Physiol       Date:  2011-04-11       Impact factor: 5.182

2.  NKCC1 and NKCC2: The pathogenetic role of cation-chloride cotransporters in hypertension.

Authors:  Sergei N Orlov; Svetlana V Koltsova; Leonid V Kapilevich; Svetlana V Gusakova; Nickolai O Dulin
Journal:  Genes Dis       Date:  2015-06

3.  Zebrafish WNK lysine deficient protein kinase 1 (wnk1) affects angiogenesis associated with VEGF signaling.

Authors:  Ju-Geng Lai; Su-Mei Tsai; Hsiao-Chen Tu; Wen-Chuan Chen; Fong-Ji Kou; Jeng-Wei Lu; Horng-Dar Wang; Chou-Long Huang; Chiou-Hwa Yuh
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

4.  Genome-wide association study of red blood cell traits in Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos.

Authors:  Chani J Hodonsky; Deepti Jain; Ursula M Schick; Jean V Morrison; Lisa Brown; Caitlin P McHugh; Claudia Schurmann; Diane D Chen; Yong Mei Liu; Paul L Auer; Cecilia A Laurie; Kent D Taylor; Brian L Browning; Yun Li; George Papanicolaou; Jerome I Rotter; Ryo Kurita; Yukio Nakamura; Sharon R Browning; Ruth J F Loos; Kari E North; Cathy C Laurie; Timothy A Thornton; Nathan Pankratz; Daniel E Bauer; Tamar Sofer; Alex P Reiner
Journal:  PLoS Genet       Date:  2017-04-28       Impact factor: 6.020

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.